✦ LIBER ✦

Third-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer — Is There Enough Evidence to Support Its Use?

✍ Scribed by Chih-Hsin Yang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retrospective Analysis of Third-Line and

✍ Hajime Asahina; Ikuo Sekine; Hidehito Horinouchi; Hiroshi Nokihara; Noboru Yamam 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 268 KB

Best supportive care in non-small cell l

✍ Numico, Gianmauro; Russi, Elvio; Merlano, Marco 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Erratum to: Evaluation of S-1 as third-

✍ Akira Ono; Tateaki Naito; Haruyasu Murakami; Toshiaki Takahashi; Yukiko Nakamura 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 85 KB

Erlotinib or best supportive care for th

✍ Cromwell, Ian; van der Hoek, Kimberly; Malfair Taylor, Suzanne C.; Melosky, Barb 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Growing clinical evidence for the intera

✍ Daniela Kandioler; Georgios Stamatis; Wilfried Eberhardt; Sonja Kappel; Sabine Z 📂 Article 📅 2008 🏛 CTSNet 🌐 English ⚖ 145 KB

Is there a standard regimen for first-li

✍ Pallis, Athanasios G.; Georgoulias, Vassilis 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 235 KB